Fact CheckerSign in

NCT06636721Not yet recruiting

Lung Cancer and Aging: Improving Well-being for Older Adults With Lung Cancer

Lung Cancer and Aging (LuCA): Intervention Development for Addressing Aging-specific Concerns in Older Adults With Lung Cancer

Source: ClinicalTrials.gov · Last updated 28 Aug 2026

Brief summary (registry, in English)

The purpose of this study is to develop a brief assessment and need-based behavioral intervention for addressing aging-specific concerns in older adults with lung cancer. The long-term goals of this research include identifying the unique concerns of these patients, providing patients with behavioral skills to address their symptom management needs, and enhancing patient engagement with healthcare specialties targeting aging-specific concerns. In the first phase of this study, participants (12 patients with lung cancer, 6 caregivers, 12 providers) will be asked to participate in two individual interviews (each 30-45 minutes in length) via teleconference. During the first interview, participants will be asked to provide feedback on the current version of the assessment and behavioral intervention. Participants will be asked to describe strengths and weaknesses of the materials, topics to add or remove, and any other suggested changes. After the research team has made changes to the materials, participants will be invited to complete a second interview to provide feedback on the updated materials. In the second phase of the study, 16 older adults with lung cancer will complete the revised assessment and participate in the behavioral intervention, in order to a) evaluate the feasibility and acceptability of the program and b) measure change in depression, anxiety, pain, and dyspnea. \*\* Phase I of the study was previously factored into the record via the overall status and start date, but the record has been revised as of 08-2026 and is now only a reflection of Phase II.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
16 (estimated)
First submitted
8 Oct 2024
Start date
1 Oct 2026
Primary completion date
1 May 2027
Lead sponsor
Duke University
Diseases
Lung cancer
NCT number
NCT06636721

What you commit to

  • Study type: Interventional
  • Planned participants: 16
  • From 1 Oct 2026 to the primary completion date, 1 May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Visual or hearing impairment, cognitive impairment, or severe mental illness interfering with participation

Who the study is looking for

  • Lung cancer diagnosis
  • 60 years of age or older
  • Receiving active treatment at Duke University Health System
  • Able to speak/read English and provide informed consent

Age in the registry: 60 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Duke University Health System
Coordinator of this site? Confirm its status
DurhamUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.